Zdravlje a.d.
Levent Selamoglu is an accomplished executive with extensive experience in leadership roles across various industries. Currently serving as Chairperson at Afrigen Biologics (Pty) Ltd and Zdravlje Leskovac, and a Board Member at Perfektüp Ambalaj, Levent also holds the position of Executive Chairman at Frontier Pharma since 2016. In addition, Levent has been a Member of the Board of Directors at SAYA HOLDING since 2015. Previous roles include CEO at Mustafa Nevzat İlaç from 2004 to 2015 and advisor at Polpharma from 2015 to 2017. Early in the career, Levent worked in senior financial positions at GSK Turkey, Ericsson Telekomunikasyon AS, and The Coca-Cola Export Corp. Academic qualifications include a BA in Economics from Boğaziçi University and an MBA from Istanbul University.
This person is not in any teams
This person is not in any offices
Zdravlje a.d.
Pharmaceutical and Chemical Industry Zdravlje Leskovac is a leader in the Balkan pharmaceutical industry. Zdravlje, which is a Serbian word for “Health”, has a 70-year-long history of manufacturing first-class pharmaceutical products at the highest international standards. From April the 1st 2021, Zdravlje continues its journey as an independent pharmaceutical company under the ownership of Frontier Pharma and Baystone Group, highly experienced UK-based pharmaceutical investors and entrepreneurs. Founded in 1953 by a small group of enthusiastic pharma professionals, Zdravlje’s history is filled with seven decades of production, marketing, and sales worldwide, as well as successful cooperation with the biggest names in the industry like BOEHRINGER, PFIZER, LEDERLE, CLIN MYDI, WELLCOMME, MADAUS, GRÜNENTHAL, Dr DRALLE, SCHWARZKOPF, TRAVENOL, POLYMER TECHNOLOGY... After almost two decades working as a part of Actavis and Teva, launching a new facility in compliance with EU GMP and EHS standards, and receiving several awards in the category of the best quality and performance manufacturing site, from April the 1st 2021, Zdravlje formally starts to operate under the ownership of Frontier Pharma and Baystone Group as an independent pharmaceutical company and a Balkan leader in this industry.